Rescripted‘s “State of Sex Ed in 2023” report exposes alarming realities about sex education in the digital age. Despite relying on social media for information, 76% of individuals distrust it as a source of misinformation. Moreover, the survey of 1,000 Rescripted community members highlights a lack of self-awareness, with only 29% feeling like experts on their own bodies. Inadequate Knowledge The report…
Five years ago in a rapidly evolving world, where conversations about intimacy were often hushed and products remained hidden in the shadows, sexologist Rebecca Alvarez Story, set out on a remarkable mission. With years of experience supporting individuals on their journeys towards sexual wellness, she recognized the need for a paradigm shift in the space and created Bloomi, a category-defining brand that…
The Center for Intimacy Justice (CIJ) has filed a complaint with the Federal Trade Commission (FTC) requesting that the FTC take action regarding Meta’s systemic rejections of women’s health information and advertisements. Today, a number of Congressmembers — led by Senators Elizabeth Warren, Amy Klobuchar, Mazie Hirono, Peter Welch, and Representative Adam Schiff — published a public letter to the FTC asking…
Australian remote healthcare company Midnight Health has raised $24M in Series B funding leb by nib, an insurer and strategic investor, bringing the company’s total funding since inception in 2021 to $40M. The capital injection will support Midnight Health’s growth throughout Australia, will boost IT infrastructure, and help the company refine its service platforms. Nic Blair, Midnight Health’s CEO, comments: “We’re really…
In a breakthrough development for men’s sexual health, the US Food and Drug Administration (FDA) has granted over-the-counter (OTC) marketing authorization to Futura Medical’s topical gel, MED3000, a first-of-its-kind treatment for erectile dysfunction (ED). The quick-acting gel formulation, delivered through Futura’s proprietary DermaSys drug delivery technology, starts working within 10 minutes of application, promising an innovative solution for millions of men globally.…
Daré Bioscience, in collaboration with Strategic Science & Technologies, has announced positive topline data from a Phase 2b study evaluating Sildenafil Cream as a treatment for female sexual arousal disorder (FSAD). The study showed meaningful improvement in the Arousal-Sensation Domain of the Sexual Function Questionnaire for patients treated with Sildenafil Cream. Additionally, improvements were observed in secondary and exploratory endpoints related to…
Swedish women’s health company Gedea Biotech has raises €1.3M (14 MSEK) to further develop its pHyph, an innovative antibiotic-free treatment for vaginal infections. Vaginal infections affect over 400 million women annually. The fresh funds will support critical development activities, including ongoing proof-of-concept studies, clinical trials, and exploring the impact of pHyph on the vaginal microbiome. The funding round attracted current and new…
German DTC startup Dr. Vivien Karl, is taking strides towards improving women’s intimate health care, and their efforts have now been bolstered by a successful round of pre-seed funding. The company has secured €1.5M from both existing investors and new ones. Notably, Dieter von Holtzbrinck Ventures (DvH Ventures) joins the funding round as the new lead investor, with Tina Müller, the former…
